Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia

Background: Sodium zirconium cyclosilicate (SZC), a newly introduced specific potassium binder, is introduced to treat hyperkalemia. However, the implications of SZC in up-titrating renin–angiotensin–aldosterone system inhibitors in patients with systolic heart failure remain unknown. Methods and Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Oshima, Akira, Narang, Nikhil, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658508/
https://www.ncbi.nlm.nih.gov/pubmed/34884224
http://dx.doi.org/10.3390/jcm10235523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658508/
https://www.ncbi.nlm.nih.gov/pubmed/34884224
http://dx.doi.org/10.3390/jcm10235523

Ejemplares similares